4
Changes in Ownership
Phathom Pharmaceuticals, Inc. Filed Acc 0001209191-20-064565
Director sold 79,658 shares at an average $43.42 ($3,458,896)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Socks David A Director | 2020-12-16 | Sale | −5,000 | $46.22 | $231,103 | 1,647,603 | I |
| Socks David A Director | 2020-12-16 | Sale | −13,292 | $47.35 | $629,366 | 1,634,311 | I |
| Socks David A Director | 2020-12-16 | Sale | −12,954 | $48.19 | $624,253 | 1,621,357 | I |
| Socks David A Director | 2020-12-16 | Sale | −200 | $48.99 | $9,798 | 1,621,157 | I |
| Socks David A Director | 2020-12-17 | Sale | −35,197 | $40.49 | $1,425,105 | 1,585,960 | I |
| Socks David A Director | 2020-12-17 | Sale | −12,915 | $41.43 | $535,071 | 1,573,045 | I |
| Socks David A Director | 2020-12-17 | Sale | −100 | $42.00 | $4,200 | 1,572,945 | I |
| Open-market sales · 79,658 sh · avg $43.42 · $3,458,896 | |||||||
Loading xslF345X03/doc4.xml…